- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05130749
Infection Prevention and Control Practices Regarding COVID-19 (IPCP)
November 19, 2021 updated by: Ayat Zammar, King Saud University
Infection Prevention and Control Practices Among Primary Healthcare Nurses Regarding COVID-19 in Saudi Arabia
Background: Healthcare providers, particularly nurses, are at risk of infection as part of the COVID-19 epidemic chain since they assist in the disease's containment.
By recognising the risk factors for infection and implementing suitable measures to reduce these risks, all reasonable efforts should be taken to control the spread of infection to them.
The major aim of the present study was to determine the level of infection prevention and control practises used by primary healthcare nurses in Saudi Arabia during the COVID-19 pandemic.
Study Overview
Study Type
Observational
Enrollment (Actual)
198
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Riyadh, Saudi Arabia, 11451
- King Saud university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
healthcare practitioners and community health nurses who worked at the aforementioned centres.
There are 800 nurses in total.
Description
Inclusion Criteria:
- Male and female healthcare practitioners with at least one year of experience and who worked in all areas of primary healthcare facilities during the COVID-19 epidemic.
Exclusion Criteria:
- Healthcare providers that are unwilling to participate in the present study have been eliminated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Primary Healthcare Nurses
Nurses allocated in primary Healthcare settings
|
The questionnaire's first section asked for demographic information such as gender, age, the name of the primary healthcare centre, and level of education.
The second section comprised sources of knowledge on COVID-19; respondents replied on a scale of 1 least used (1), occasionally (2), more frequently (3), and most used (4).
The third section had six items pertaining to nurses' infection prevention and control methods with reference to COVID-19, and respondents replied on a scale of yes (2), occasionally (1), and no (0).
Permission to use the questionnaire has been requested from the author and is awaited.
|
|
Non Nurses Primary Healthcare
Other Healthcare providers allocated in primary health care settings
|
The questionnaire's first section asked for demographic information such as gender, age, the name of the primary healthcare centre, and level of education.
The second section comprised sources of knowledge on COVID-19; respondents replied on a scale of 1 least used (1), occasionally (2), more frequently (3), and most used (4).
The third section had six items pertaining to nurses' infection prevention and control methods with reference to COVID-19, and respondents replied on a scale of yes (2), occasionally (1), and no (0).
Permission to use the questionnaire has been requested from the author and is awaited.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distribution of study participants by gender, age group, marital status, and income level in a self-reported questionnaire.
Time Frame: Once within 6 weeks
|
Demographic data included age, gender, experience, educational level, marital status, income and job will be assessed using numerical code for each demographic variable.
|
Once within 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection of source of knowledge regarding COVID-19 prevention methods
Time Frame: Once within 6 weeks
|
Using self-reporting questionnaire, will assess Social Media, Radio & television, Seminars & workshops, Posters & Pamphlets, Newspapers &Magazines and Seniors & Other Colleagues from (Least used= 1 to Most used= 4).
|
Once within 6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Circumstances when Healthcare providers practice infection prevention tasks in settings.
Time Frame: Once within 6 weeks
|
Assess the use of Personl Protective Equipments (Gloves, Mask(regular), N95 respirator mask, Surgical mask, Goggles, Apron, Gown, Isolation gown, Hair cover, Shoe cover and Eye protection) from Never(0) to Always (4).
|
Once within 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 12, 2020
Primary Completion (Actual)
September 15, 2021
Study Completion (Actual)
September 15, 2021
Study Registration Dates
First Submitted
November 16, 2021
First Submitted That Met QC Criteria
November 19, 2021
First Posted (Actual)
November 23, 2021
Study Record Updates
Last Update Posted (Actual)
November 23, 2021
Last Update Submitted That Met QC Criteria
November 19, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KSU-HE-21-35
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19 Pandemic
-
Laval UniversityCISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre... and other collaboratorsRecruiting
-
Assiut UniversityDoaa M.EL ShehabyUnknownCovid 19 Pandemic From Ethical View
-
University of JordanAysha Alkhayat; Mariam Aljweesri; Reem Alharbi; Zahraa AljazzafCompleted
-
Sialkott College of Physical TherapyCompletedBurnout, Psychological | Covid-19 PandemicPakistan
-
Istituto Auxologico ItalianoUniversity of Bergen; Catholic University of the Sacred Heart; University of... and other collaboratorsCompletedDepression | Anxiety Disorders | Stress | Social Isolation | COVID-19 Pandemic Psychological ImpactItaly
-
University of GaziantepCompleted
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
Charite University, Berlin, GermanyRecruitingAnxiety Related to the COVID-19 PandemicGermany
-
University Hospital, BrestCompletedIdentify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicFrance
-
Hospices Civils de LyonCompletedEmergency Department Staff During the COVID-19 Pandemic | Emergency Department Staff's Level of StressFrance
Clinical Trials on Questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University Medical Center GoettingenCompletedOrofacial Pain | Sleep ProblemsGermany
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
University Hospital, Clermont-FerrandCompletedQuality of Life | Dentin HypersensitivityFrance